Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Market Cap	1.18T
Revenue (ttm)	575.66B
Net Income (ttm)	27.92B
Shares Out	31.51M
EPS (ttm)	980.93
PE Ratio	38.28
Forward PE	27.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,660,827
Average Volume	4,345,529
Open	35,700
Previous Close	35,800
Day's Range	35,100 - 38,300
52-Week Range	10,300 - 45,050
Beta	1.01
RSI	59.78
Earnings Date	Feb 6, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 1,061
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 249420

Financial Performance

In 2024, Ildong Pharmaceutical's revenue was 614.94 billion, an increase of 2.36% compared to the previous year's 600.76 billion. Losses were -4.58 billion, -94.20% less than in 2023.